September 6, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attn: Daniel Crawford
| Re: | Forte Biosciences, Inc. |
Registration Statement on Form S-3
File No. 333-274257
Acceleration Request
Requested Date: September 8, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Forte Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-274257) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Dan Koeppen at (858) 350-2393 or via email at dkoeppen@wsgr.com.
| Sincerely, |
| FORTE BIOSCIENCES, INC. |
/s/ Paul A. Wagner, Ph.D. |
| Paul A. Wagner, Ph.D. |
| Chief Executive Officer |
| cc: | Dan Koeppen, Wilson Sonsini Goodrich & Rosati, P.C. |
